IN VIVO CONTROLLED COMBINATION THERAPY FOR TREATMENT OF CANCER Application EP-3813854-A4 European Patent Office 08 Jun 2022
Anti-PD-1 antibodies and methods of use thereof Grant US-11345755-B2 United States of America 31 May 2022
Intralesional administration of PD-1 inhibitors for the treatment of skin cancer Application CN-113038939-A China 25 Jun 2021
LEUKADHERIN-1 ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF CANCER Application WO-2020236668-A1 World Intellectual Property Organisation (WIPO) 26 Nov 2020